Hyphens Pharma International Limited Stock

Equities

1J5

SG1EE4000006

Pharmaceuticals

Market Closed - Singapore S.E. 11:25:03 2024-04-18 pm EDT 5-day change 1st Jan Change
0.27 SGD -1.82% Intraday chart for Hyphens Pharma International Limited 0.00% -5.26%
Sales 2023 171M 125M Sales 2024 * 183M 134M Capitalization 83.36M 61.23M
Net income 2023 8M 5.88M Net income 2024 * 11M 8.08M EV / Sales 2023 0.52 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 0.46 x
P/E ratio 2023
10.3 x
P/E ratio 2024 *
7.51 x
Employees 355
Yield 2023
15.6%
Yield 2024 *
3.93%
Free-Float 18.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.82%
Current month+1.89%
1 month-5.26%
3 months-3.57%
6 months-3.57%
Current year-5.26%
More quotes
1 week
0.27
Extreme 0.27
0.28
1 month
0.27
Extreme 0.265
0.29
Current year
0.27
Extreme 0.265
0.31
1 year
0.27
Extreme 0.265
0.35
3 years
0.27
Extreme 0.265
0.38
5 years
0.18
Extreme 0.18
0.63
10 years
0.16
Extreme 0.16
0.63
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 97-12-31
Director of Finance/CFO - 22-12-31
Chief Operating Officer 59 19-08-31
Members of the board TitleAgeSince
Director/Board Member 59 18-04-22
Director/Board Member 52 20-11-04
Chief Executive Officer 56 97-12-31
More insiders
Date Price Change Volume
24-04-19 0.27 -1.82% 105,000
24-04-18 0.275 0.00% 70,000
24-04-17 0.275 +1.85% 28,000
24-04-16 0.27 0.00% 40,000
24-04-15 0.27 0.00% 25,000

Delayed Quote Singapore S.E., April 18, 2024 at 11:25 pm EDT

More quotes
Hyphens Pharma International Limited is a Singapore-based specialty pharmaceutical and consumer healthcare company. The Company's principal activities are those of an investment holding company and provision of management services. The Company's segments include Specialty pharma principals, Proprietary brands, and Medical hypermart and digital. The Specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The Proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The Medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position themselves as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.27 SGD
Average target price
0.35 SGD
Spread / Average Target
+29.63%
Consensus

Annual profits - Rate of surprise